KIT and systemic mastocytosis: Whilst the rate of patient progression from indolent to advanced SM is low, there are a number of prognostic variables than can predict progression including multilineal KIT D816V mutation, the variant allele frequency (VAF) of mutated KIT and an elevated β2-microglobulin7,25.